JXSL1700092 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Import Drug Application | 2018-01-02 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2018-11-12 | view |
CXSL2300177 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(3.3) | New Drug Application | 2023-03-08 | | Nanjing Han Xin Pharmaceutical Technology Co Ltd | | | view |
JYSB1900217 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2019-08-27 | 丹麦诺和诺德公司 | Novo Nordisk A/S | In Review | 2019-08-26 | view |
JYSB1100208 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2011-09-05 | 诺和诺德(中国)制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | Certificate Issued | 2012-08-15 | view |
CYSB2200235 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2022-09-28 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
CXSL0900033 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(15) | New Drug Application | 2010-01-15 | 甘李药业有限公司 | Gan & Lee Pharmaceuticals | Certificate Issued | 2011-08-03 | view |
CYSB2200229 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2022-09-15 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
JYSB2000186 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2020-05-13 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Filed | 2020-05-19 | view |
JYSB1200262 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2012-11-14 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2016-05-16 | view |
JYSB1800206 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2018-10-11 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2019-05-17 | view |
CYSB2101163 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2021-08-20 | | Gan & Lee Pharmaceuticals | | | view |
JYSB0900238 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2010-02-05 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2011-03-07 | view |
CXSL1700221 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(15) | New Drug Application | 2018-04-26 | 北京双鹭药业股份有限公司 | Beijing SL Pharmaceutical Co Ltd | In Review | 2018-04-25 | view |
CYSB2200228 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2022-09-15 | | Tonghua Dongbao Pharmaceutical Co Ltd | | | view |
CXSS1700029 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(15) | New Drug Application | 2018-01-18 | 珠海联邦制药股份有限公司 | Zhuhai United Laboratories Co Ltd | Certificate Issued | 2021-07-16 | view |
JYSB1900347 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2019-12-16 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2019-12-31 | view |
CXSL1200032 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(15) | New Drug Application | 2012-05-17 | 通化东宝药业股份有限公司 | Tonghua Dongbao Pharmaceutical Co Ltd | Certificate Issued | 2013-01-30 | view |
CYSB2400166 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(3.3) | Supplementary Application | 2024-07-02 | | Yichang HEC Changjiang Pharmaceutical Co Ltd | | | view |
JYSB0700030 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2007-03-02 | 丹麦诺和诺德公司 | Novo Nordisk A/S | Certificate Issued | 2008-04-22 | view |
CYSB1200366 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2013-11-14 | 诺和诺德(中国)制药有限公司 | Novo Nordisk (China) Pharmaceuticals Co Ltd | Certificate Issued | 2015-03-11 | view |